The Company announced that it is sharpening its strategic focus to innovative radiodiagnostics and is prioritizing its investment in the development and commercialization of innovative PET radiodiagnostics, alongside a decision to pursue value-maximizing alternatives for radiotherapeutic assets to support long-term growth. Completed the divestiture of the legacy SPECT business to SHINE Technologies, a decisive action taken to focus on PET radiodiagnostics and simplify the Company’s operating model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: